Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, De Angelis L, Raizer J, Hess K, Aldape K, Lamborn KR, Kuhn J, Dancey J, Prados MD; North American Brain Tumor Consortium and the National Cancer Institute.
Chang SM, et al. Among authors: raizer j.
Invest New Drugs. 2005 Aug;23(4):357-61. doi: 10.1007/s10637-005-1444-0.
Invest New Drugs. 2005.
PMID: 16012795
Free article.
Clinical Trial.